Teva Pharmaceuticals International Gmbh v. Eli Lilly and Company
Opinion
Case: 24-1149 Document: 3 Page: 1 Filed: 09/08/2025
NOTE: This order is nonprecedential.
United States Court of Appeals for the Federal Circuit
______________________
TEVA PHARMACEUTICALS INTERNATIONAL GMBH, TEVA PHARMACEUTICALS USA, INC.,
Plaintiffs-Appellants v.
ELI LILLY AND COMPANY, Defendant-Cross-Appellant ______________________ 2024-1094 ______________________
Appeal from the United States District Court for the District of Massachusetts in No. 1:18-cv-12029-ADB, Judge Allison Dale Burroughs.
------------------------------------------- TEVA PHARMACEUTICALS INTERNATIONAL GMBH, TEVA PHARMACEUTICALS USA, INC.,
Plaintiffs-Appellants v.
ELI LILLY AND COMPANY, Defendant-Cross-Appellant ______________________ 2024-1149
Case: 24-1149 Document: 3 Page: 2 Filed: 09/08/2025 2 TEVA PHARMACEUTICALS INTERNATIONAL GMBH v.
ELI LILLY AND COMPANY
______________________
Appeal from the United States District Court for the District of Massachusetts in No. 1:18-cv-12029-ADB, Judge Allison Dale Burroughs.
______________________ ORDER
Mylan Pharmaceuticals Inc. and Bausch Health Ire- land Ltd stipulate to voluntary dismissal of Appeal No. 24- 1149.
The parties, having so agreed, IT IS ORDERED THAT: (1) Appeal No. 24-1149 is dismissed under Fed. R. App. P. 42(b), with each side to bear their own costs.
(2) The official captions as modified, are reflected in this order.
FOR THE COURT September 8, 2025
Date ISSUED AS A MANDATE (as to Appeal No. 24-1149 only): September 8, 2025.
Case-law data current through September 30, 2026. Source: CourtListener bulk data.